Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 6

Prophylaxis of migraine: general principles and patient acceptance

Authors Domenico D’Amico, Stewart J Tepper

Published 5 December 2008 Volume 2008:4(6) Pages 1155—1167

DOI https://doi.org/10.2147/NDT.S3497

Review by Single-blind

Peer reviewer comments 3

Domenico D’Amico1, Stewart J Tepper2

1Headache Center, Department of Neurological Sciences, C Besta Neurological Institute, Milan, Italy; 2Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Abstract: Migraine is a chronic neurological condition with episodic exacerbations. Migraine is highly prevalent, and associated with significant pain, disability, and diminished quality of life. Migraine management is an important health care issue. Migraine management includes avoidance of trigger factors, lifestyle modifications, non-pharmacological therapies, and medications. Pharmacological treatment is traditionally divided into acute or symptomatic treatment, and preventive treatment or prophylaxis. Many migraine patients can be treated using only acute treatment. Patients with severe and/or frequent migraines require long-term preventive therapy. Prophylaxis requires daily administration of anti-migraine compounds with potential adverse events or contraindications, and may also interfere with other concurrent conditions and treatments. These problems may induce patients to reject the idea of a preventive treatment, leading to poor patient adherence. This paper reviews the main factors influencing patient acceptance of anti-migraine prophylaxis, providing practical suggestions to enhance patient willingness to accept pharmacological anti-migraine preventive therapy. We also provide information about the main clinical characteristics of migraine, and their negative consequences. The circumstances warranting prophylaxis in migraine patients as well as the main characteristics of the compounds currently used in migraine prophylaxis will also be briefly discussed, focusing on those aspects which can enhance patient acceptance and adherence.

Keywords: migraine, prophylaxis, preventive therapy, acceptance, adherence

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Synthesis, characterization, and antimicrobial activity of an ampicillin-conjugated magnetic nanoantibiotic for medical applications

Hussein-Al-Ali SH, El Zowalaty ME, Hussein MZ, Geilich BM, Webster TJ

International Journal of Nanomedicine 2014, 9:3801-3814

Published Date: 8 August 2014

Association between dental pulp stones and calcifying nanoparticles

Jinfeng Zeng, Fang Yang, Wei Zhang, et al

International Journal of Nanomedicine 2011, 6:109-118

Published Date: 7 January 2011

Maraviroc in the treatment of HIV infection

Neelanjana Ray

Drug Design, Development and Therapy 2008, 2:151-161

Published Date: 20 August 2008

Editorial: One year of Clinical Ophthalmology ||Free Paper||

Scott G Fraser

Clinical Ophthalmology 2007, 1:353-353

Published Date: 15 February 2008

Treatment of phantom bite syndrome with milnacipran - a case series

Akira Toyofuku, Toshihiro Kikuta

Neuropsychiatric Disease and Treatment 2006, 2:387-390

Published Date: 15 September 2006